These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22860091)

  • 1. RhoT1 and Smad4 are correlated with lymph node metastasis and overall survival in pancreatic cancer.
    Jiang H; He C; Geng S; Sheng H; Shen X; Zhang X; Li H; Zhu S; Chen X; Yang C; Gao H
    PLoS One; 2012; 7(7):e42234. PubMed ID: 22860091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study.
    Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H
    World J Surg Oncol; 2015 Mar; 13():128. PubMed ID: 25890228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral Heterogeneity of SMAD4 Immunohistochemical Expression and Its Role in Prediction of Recurrence Pattern in Patients with Resectable Pancreatic Cancer.
    Pokataev I; Kudaibergenova A; Artemyeva A; Popova A; Rumyantsev A; Podluzhny D; Kudashkin N; Fedyanin M; Tryakin A; Tjulandin S
    J Gastrointest Cancer; 2019 Sep; 50(3):478-484. PubMed ID: 29675723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMAD4 expression predicts local spread and treatment failure in resected pancreatic cancer.
    Yamada S; Fujii T; Shimoyama Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
    Pancreas; 2015 May; 44(4):660-4. PubMed ID: 25760429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.
    Biankin AV; Morey AL; Lee CS; Kench JG; Biankin SA; Hook HC; Head DR; Hugh TB; Sutherland RL; Henshall SM
    J Clin Oncol; 2002 Dec; 20(23):4531-42. PubMed ID: 12454109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
    Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
    Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of RHOT1 on migration and proliferation of pancreatic cancer.
    Li Q; Yao L; Wei Y; Geng S; He C; Jiang H
    Am J Cancer Res; 2015; 5(4):1460-70. PubMed ID: 26101710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-Myc and Fas correlates with perineural invasion of pancreatic cancer.
    He C; Jiang H; Geng S; Sheng H; Shen X; Zhang X; Zhu S; Chen X; Yang C; Gao H
    Int J Clin Exp Pathol; 2012; 5(4):339-46. PubMed ID: 22670178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.
    Wang P; Fan J; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Xu ZD; Liu LM
    Ann Surg Oncol; 2009 Apr; 16(4):826-35. PubMed ID: 19165547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorly differentiated histologic grade correlates with worse survival in SMAD4 negative pancreatic adenocarcinoma patients.
    Park JY; King J; Reber H; Joe Hines O; Mederos MA; Wang HL; Dawson D; Wainberg Z; Donahue T; Girgis M
    J Surg Oncol; 2021 Feb; 123(2):389-398. PubMed ID: 33146409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer.
    Yang YH; Liu JB; Gui Y; Lei LL; Zhang SJ
    World J Gastroenterol; 2017 Oct; 23(40):7232-7241. PubMed ID: 29142470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Effect of Driver Mutations of
    Gu Y; Ji Y; Jiang H; Qiu G
    Genet Test Mol Biomarkers; 2020 Dec; 24(12):777-788. PubMed ID: 33347393
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer].
    Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF
    Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression.
    Winter JM; Tang LH; Klimstra DS; Liu W; Linkov I; Brennan MF; DʼAngelica MI; DeMatteo RP; Fong Y; Jarnagin WR; Oʼreilly EM; Allen PJ
    Ann Surg; 2013 Aug; 258(2):331-5. PubMed ID: 23360922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival.
    Kadera BE; Sunjaya DB; Isacoff WH; Li L; Hines OJ; Tomlinson JS; Dawson DW; Rochefort MM; Donald GW; Clerkin BM; Reber HA; Donahue TR
    JAMA Surg; 2014 Feb; 149(2):145-53. PubMed ID: 24306217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Lazor JW; Sperry J; Jin C; Cao L; Freeman JW
    Cancer Res; 2008 Jun; 68(11):4221-8. PubMed ID: 18519681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
    Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X
    Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive examination of Smad4, Smad6 and Smad7 mRNA expression in pancreatic ductal adenocarcinoma.
    Singh P; Wig JD; Srinivasan R; Radotra BD
    Indian J Cancer; 2011; 48(2):170-4. PubMed ID: 21768661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of SMAD4 staining in pre-operative cell blocks is associated with distant metastases following pancreaticoduodenectomy with venous resection for pancreatic cancer.
    Boone BA; Sabbaghian S; Zenati M; Marsh JW; Moser AJ; Zureikat AH; Singhi AD; Zeh HJ; Krasinskas AM
    J Surg Oncol; 2014 Aug; 110(2):171-5. PubMed ID: 24665063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.